Brian L. Stekloff
Brian L. Stekloff is a founding partner of Wilkinson Walsh. He has successfully tried numerous civil and criminal cases to federal juries across the country. Brian also represents companies and individuals in government investigations and prosecutions. Before founding the firm, Brian practiced at Covington & Burling and Paul, Weiss, Rifkind, Wharton & Garrison in Washington, DC.
- Undergraduate: University of North Carolina at Chapel Hill, B.A. with distinction
- Law: Georgetown University Law Center, J.D. magna cum laude (Order of the Coif)
- Judge Catherine C. Blake, United States District Court for the District of Maryland (2001-03)
- Judge J. Frederick Motz, United States District Court for the District of Maryland (2001-03)
- Served as lead trial counsel in Russell v. Janssen in the Philadelphia Court of Common Pleas. The trial was the second state-court bellwether trial over the blood-thinner Xarelto and resulted in a full defense verdict when the jury rejected claims against Bayer AG and Johnson & Johnson subsidiary Janssen Pharmaceuticals. The plaintiff in the Russell case alleged that Bayer and Janssen were liable for claims that the Xarelto label did not adequately instruct doctors on the risks of bleeding associated with the Anticoagulant Xarelto.
- Successfully co-tried a two-plaintiff jury trial in federal court for Eli Lilly and Company regarding the antidepressant Cymbalta and allegations that Eli Lilly failed to warn of discontinuation risks.
- Successfully co-tried two separate trials in federal court for Pfizer as part of a multi-district litigation regarding the hormone therapy medication Prempro and allegations that Pfizer failed to warn of the risk of developing breast cancer.
- Served as a key member of the defense team representing the NFL in its landmark concussion litigation class action settlement and in related cases for the Kansas City Chiefs and Arizona Cardinals.
- Successful representation of Pfizer in defending an antitrust case in which plaintiffs claimed Pfizer engaged in a patent-stacking scheme to delay generic entry and maintain a monopoly for Neurontin.
Benchmark Litigation "Under 40 Hotlist" 2016
Clients & Industries
Brian’s broad practice has included representation of plaintiffs and defendants in products liability, sports, financial services, and healthcare. He has represented Fortune 500 Companies – including Bayer, Eli Lilly, JP Morgan, the National Football League, and Pfizer. In 2015, Brian was part of the team that The American Lawyer recognized as "Litigation Department of the Year: Product Liability."
From 2006 to 2010, Brian served as an Assistant Federal Public Defender for the Southern District of Florida in Miami. In that capacity, he represented indigent defendants in a variety of criminal cases involving alleged securities and other financial fraud, political corruption, violent crimes, narcotics and immigration offenses. As an Assistant Federal Public Defender, Brian chaired or co-chaired twenty-two felony jury trials, including seven full acquittals. Brian has remained involved in representing indigent defendants on a pro bono basis as a member of the Criminal Justice Act Panel for the District of Maryland.